A Phase 2b Dose-Ranging Efficacy and Safety Study of Tralokinumab in Adult Patients With Moderate to Severe Atopic Dermatitis

SKIN The Journal of Cutaneous Medicine

doi 10.25251/skin.2.supp.28

Full Text

Abstract

Available in

Date

Authors

Publisher

National Society for Cutaneous Medicine


Related search